World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
63
Citations
14600
World Ranking
3022
National Ranking
1416

Overview

Dharam V. Ablashi is affiliated with Georgetown University in the United States and focuses primarily on research within the field of Medicine. Their work spans several subfields, including Infectious Diseases, Nutrition and Dietetics, Molecular Biology, and Immunology. This diverse range reflects a broad engagement with topics relevant to health sciences and biomedical research.

Their recent scholarly output includes studies published in specialized journals. Notable papers comprise "Transfer Factor as an Option for Managing the COVID-19 Pandemic," published in 2020 in Folia Biologica, and "The effects of Avemar treatment on feline immunodeficiency virus infected cell cultures," published in 2023 in Veterinary Medicine and Science. These publications indicate an interest in viral diseases and their clinical and therapeutic implications.

Their work addresses several interconnected themes, such as:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Viral gastroenteritis research and epidemiology
  • Food Science and Nutritional Studies
  • Plant tissue culture and regeneration
  • Toxin Mechanisms and Immunotoxins

Throughout their research career, Ablashi has collaborated with various co-authors, including D. Viza, Giovanni Pizza, Concetta Vinci, Giovanni Brandi, and Katalin Réka Tarcsai. These collaborations span different projects and represent professional partnerships within overlapping research interests.

The primary venues for their publications include Folia Biologica and Veterinary Medicine and Science, reflecting the interdisciplinary and translational nature of their work. These journals serve as platforms for disseminating findings related to infectious diseases and veterinary aspects of viral infections.

Best Publications

  • Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders

    SZ Salahuddin;DV Ablashi;PD Markham;SF Josephs

  • A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection.

    Dedra Buchwald;Paul R. Cheney;Daniel L. Peterson;Berch Henry

  • Spectrum of Kaposi's Sarcoma-Associated Herpesvirus, or Human Herpesvirus 8, Diseases

    Dharam V. Ablashi;Louise G. Chatlynne;James E. Whitman;Ethel Cesarman

  • Chromosomally integrated human herpesvirus 6: questions and answers

    Philip E. Pellett;Dharam V. Ablashi;Peter F. Ambros;Henri Agut

  • The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro

    Jesse H. Arbuckle;Maria M. Medveczky;Janos Luka;Stephen H. Hadley

  • In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6).

    P Lusso;P D Markham;E Tschachler;F di Marzo Veronese

  • Classification of HHV-6A and HHV-6B as distinct viruses.

    Dharam Ablashi;Henri Agut;Roberto Alvarez-Lafuente;Duncan A. Clark

  • Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6.

    Paolo Lusso;Barbara Ensoli;Phillip D. Markham;Dharam V. Ablashi

  • Genomic analysis of the human B-lymphotropic virus (HBLV).

    SF Josephs;SZ Salahuddin;DV Ablashi;F Schachter

  • Human herpesvirus 7 is a T-lymphotropic virus and is related to, but significantly different from, human herpesvirus 6 and human cytomegalovirus.

    Zwi N. Berneman;Dharam V. Ablashi;Ge Li;Maureen Eger-Fletcher

  • Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients

    D.V Ablashi;H.B Eastman;C.B Owen;M.M Roman

  • Human B-lymphotropic virus (human herpesvirus-6).

    D.V. Ablashi;S.F. Josephs;A. Buchbinder;K. Hellman

  • Human herpesvirus-6 strain groups: a nomenclature

    D. Ablashi;H. Agut;Z. Berneman;G. Campadelli-Fiume

  • Immunosuppressive effect of human herpesvirus 6 on T-cell functions: suppression of interleukin-2 synthesis and cell proliferation.

    Louis Flamand;Jean Gosselin;Irina Stefanescu;Dharam Ablashi

  • Detection and Titration of Human Herpesvirus-8–Specific Antibodies in Sera From Blood Donors, Acquired Immunodeficiency Syndrome Patients, and Kaposi's Sarcoma Patients Using a Whole Virus Enzyme-Linked Immunosorbent Assay

    Louise G. Chatlynne;William Lapps;Michael Handy;Yao Q. Huang

  • Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors.

    Philip E. Pellett;D. J. Wright;E. A. Engels;D. V. Ablashi

  • Upregulation of the 2-5A Synthetase/RNase L Antiviral Pathway Associated with Chronic Fatigue Syndrome

    Robert J. Suhadolnik;Nancy L. Reichenbach;Patricia Hitzges;Robert W. Sobol

  • Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus 6).

    Dharam V. Ablashi;Paolo Lusso;Chia-Ling Hung;S. Zaki Salahuddin

  • Seroepidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV)

    Louise G. Chatlynne;Dharam V. Ablashi

  • Human Herpesvirus-6 (HHV-6) infection in multiple sclerosis: a preliminary report.

    D V Ablashi;W Lapps;M Kaplan;J E Whitman

Frequent Co-Authors

Robert C. Gallo
Robert C. Gallo University of South Florida
Louis Flamand
Louis Flamand Université Laval
Gary R. Pearson
Gary R. Pearson Georgetown University
Paolo Lusso
Paolo Lusso National Institutes of Health
Tetsushi Yoshikawa
Tetsushi Yoshikawa Fujita Health University
Phillip D. Markham
Phillip D. Markham Northrop Grumman (United States)
Parkash S. Gill
Parkash S. Gill University of Southern California
Steven Jacobson
Steven Jacobson National Institutes of Health
Peter Biberfeld
Peter Biberfeld Karolinska Institute
Irmeli Lautenschlager
Irmeli Lautenschlager University of Helsinki

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare and research careers. Many students complement their immunology background with nursing qualifications to expand their clinical skills and job prospects. For those seeking fast-track options, 12-month accelerated nursing programs offer a quick path to becoming a registered nurse, building on prior education or experience.

Entry-level nursing roles can also lead to specialization in immunology-related fields. The best easiest lpn programs to get into provide accessible options for those starting their nursing careers, which can later evolve into more advanced roles with further education.

For graduates interested in advanced clinical roles, pursuing easiest online nurse practitioner programs allows for flexible learning while gaining in-depth patient care expertise. Some nurse practitioners focus in mental health, linking immunological research with psychiatric care. For these professionals, online pmhnp programs with clinical placement ensure hands-on experience in mental health settings, crucial for advancing their careers.

Overall, integrating immunology studies with nursing pathways can lead to fulfilling careers in healthcare, research, and patient advocacy, supported by a wide range of accessible and accelerated online degree options.

Best Scientists Citing Dharam V. Ablashi

Trending Scientists